Table 2 Baseline Characteristics
LVPEG-1 | LVPEG-2 | LVPEG-3 | Control | LVPEG-3 | LVPEG-4 | LVPEG-5 | Control | |
|---|---|---|---|---|---|---|---|---|
Study Part | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 |
Patients, n | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 |
Age, years (mean ± SD) | 53.2 ± 8.2 | 53.4 ± 8.0 | 55.4 ± 8.2 | 51.2 ± 8.4 | 60.4 ± 5.7 | 60.0 ± 6.3 | 61.9 ± 6.7 | 58.8 ± 6.1 |
Gender, n (%) | ||||||||
Male | 17 (56.7) | 17 (56.7) | 18 (60.0) | 18 (60.0) | 14 (46.7) | 13 (43.3) | 13 (43.3) | 14 (46.7) |
Female | 13 (43.3) | 13 (43.3) | 12 (40.0) | 12 (40.0) | 16 (53.3) | 17 (56.7) | 17 (56.7) | 16 (53.3) |
Race, n (%) | ||||||||
White or Caucasian | 30 (100.0) | 29 (96.7) | 30 (100.0) | 30 (100.0) | 30 (100.0) | 30 (100.0)a | 30 (100.0) | 30 (100.0) |
Other | 0 | 1 (3.3) | 0 | 0 | 0 | 0 | 0 | 0 |
BMI (kg/m2, mean ± SD) | 25.4 (2.8) | 25.5 (2.2) | 25.2 (2.8) | 25.0 (3.3) | 25.4 (2.7) | 25.9 (3.4) | 25.8 (2.9) | 25.4 (3.4) |